CATALYST PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Catalyst Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Catalyst Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was 22 %, a 45.5% increase year-over-year.
  • Catalyst Pharmaceuticals, Inc. annual Return On Assets for 2023 was 16.5 %, a 39.4% decline from 2022.
  • Catalyst Pharmaceuticals, Inc. annual Return On Assets for 2022 was 27.2 %, a 49.2% increase from 2021.
  • Catalyst Pharmaceuticals, Inc. annual Return On Assets for 2021 was 18.2 %, a 62.6% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 22 +6.88 +45.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 12.2 -17.4 -58.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 13.2 -15.6 -54.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 16.5 -10.7 -39.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 15.1 -9.53 -38.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 29.6 +7.28 +32.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 28.8 +9.09 +46.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 27.2 +8.96 +49.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 24.7 +4.42 +21.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 22.4 -16.2 -42.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 19.7 -21.9 -52.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 18.2 -30.4 -62.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 20.3 -33 -62% Jul 1, 2021 Sep 30, 2021
Q2 2021 38.6 +2.14 +5.87% Apr 1, 2021 Jun 30, 2021
Q1 2021 41.5 -0.88 -2.08% Jan 1, 2021 Mar 31, 2021
Q4 2020 48.7 +12.1 +32.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 53.3 +40.5 +318% Jul 1, 2020 Sep 30, 2020
Q2 2020 36.5 +54.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 42.4 +86.3 Jan 1, 2020 Mar 31, 2020
Q4 2019 36.6 +84.9 Oct 1, 2019 Dec 31, 2019
Q3 2019 12.8 +45.2 Jul 1, 2019 Sep 30, 2019
Q2 2019 -18 +13.1 +42.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -43.9 -11.4 -34.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -48.3 -10.3 -27% Oct 1, 2018 Dec 31, 2018
Q3 2018 -32.5 +13.4 +29.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -31.1 +11.2 +26.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -32.6 +8.09 +19.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -38 +0.1 +0.26% Oct 1, 2017 Dec 31, 2017
Q3 2017 -45.8 -7.9 -20.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -42.2 -6.64 -18.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -40.7 -7.89 -24.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -38.1 -8.04 -26.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -37.9 -9.6 -33.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -35.6 -4.03 -12.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -32.8 -0.45 -1.39% Jan 1, 2016 Mar 31, 2016
Q4 2015 -30.1 +9.2 +23.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -28.3 +10.1 +26.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -31.6 +15.2 +32.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -32.3 +31.7 +49.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -39.3 +20.7 +34.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -38.4 +21.6 +36% Jul 1, 2014 Sep 30, 2014
Q2 2014 -46.7 +7.55 +13.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -64 -27 -72.8% Jan 1, 2014 Mar 31, 2014
Q4 2013 -60 -20.8 -52.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -60 +21.8 +26.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -54.3 +29.3 +35.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -37.1 +75.7 +67.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -39.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -81.8 Jul 1, 2012 Sep 30, 2012
Q2 2012 -83.6 Apr 1, 2012 Jun 30, 2012
Q1 2012 -113 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.